Effect of Shebet Oil on Knee Arthrosis

Comparison of the effect of Shebet Oil and Diclofenac Gel on clinical symptoms in patients with Knee osteoarthritis: A randomized, double-blind, controlled Clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201012055315N1

Enrollment

Registered

2011-04-20

Start date

2010-07-14

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis. Primary arthrosis of other joints

Interventions

Intervention 1: shebet oil. Knee local use. Dosage 2 grams per use 3 times a day. Patients will be visited at the 0, 2, 4 weeks of the study. Intervention 2: Pluse control group: diclofenac gel group.

Treatment - Drugs

shebet oil. Knee local use. Dosage 2 grams per use 3 times a day. Patients will be visited at the 0, 2, 4 weeks of the study.

Pluse control group: diclofenac gel group. Knee local use. Dosage 2 grams per use 3 times a day. Patients will be visited at the 0, 2, 4 weeks of the study.

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion critria: Patient's written consent for inclusion, Osteophyte in X.Ray, Knee pain Plus at least one of three: (Age>50 year, Stiffness<30 minutes, Crepitus). Exclusion Critria: Those who need more than 2 grams of acetaminophen ,Those who need to use other oral or intravenous analgesic ,Unwillingness to continue to participate in the study, Sensitivity to study drugs, Patients with other bone joint disorders:(Rhumatoid Arthrities, Gout,Pseudo Gout, Infected Arthrities, Metabolic Arthrities, Traumatic Arthrities), Joint Replacement, fibro Myalgia, Non-motor dysfunction related to hip or knee( Radiculopathy and Neuropathy), Concomitant use of glucosamine and chondrotin sulfate Knee Articular, Knee corticosteroid injection in the past 3 months, Other Articular corticosteroid injection in the past 1 months, Taking muscle relaxant drugs, Pregnancy, Oral and Local use of Corticosteroid in 14 past days, Mussle corticosteroid injection in the past 1 months Alcohol addicted, Drug Abuse, Skin Diseases in Knee, Pationts with active Renal, Liver and Peptic Ulcer Diseases, Low dose Antidepressant user for chronic pain.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Overall patient satisfaction. Timepoint: 2 Weeks. Method of measurement: Ask the patient.;Physical performance. Timepoint: 2 Weeks. Method of measurement: Womac Test.;Stifness. Timepoint: 2WEEKS. Method of measurement: womac Test.;Pain. Timepoint: 2 Weeks. Method of measurement: Womac Test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahmood Khodadoost

Traditional Medcine College

mkhodadoost@razi.tums.ac.ir; mkhodadoost2010@yahoo.com+98 21 5560 9071

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026